![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RBBP9 mRNA] | CTD | PMID:31150632 | (S)-nicotine | increases expression | ISO | RGD:736826 | 6480464 | Nicotine results in increased expression of RBBP9 mRNA | CTD | PMID:17997037 | 1,2-dimethylhydrazine | affects expression | ISO | RGD:736826 | 6480464 | 1, 2-Dimethylhydrazine affects the expression of RBBP9 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736826 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RBBP9 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RBBP9 mRNA | CTD | PMID:32109520 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1349258 | 6480464 | Lactic Acid results in decreased expression of RBBP9 mRNA | CTD | PMID:30851411 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:736826 | 6480464 | 4, 4'-diaminodiphenylmethane results in increased expression of RBBP9 mRNA | CTD | PMID:18648102 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of RBBP9 mRNA | CTD | PMID:28959563 | Aroclor 1254 | decreases expression | ISO | RGD:736826 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of RBBP9 mRNA | CTD | PMID:23650126 | atrazine | decreases expression | ISO | RGD:1349258 | 6480464 | Atrazine results in decreased expression of RBBP9 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases expression | ISO | RGD:1349258 | 6480464 | Benzo(a)pyrene results in increased expression of RBBP9 mRNA | CTD | PMID:22316170 | benzo[a]pyrene | increases expression | ISO | RGD:736826 | 6480464 | Benzo(a)pyrene results in increased expression of RBBP9 mRNA | CTD | PMID:22228805 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RBBP9 mRNA | CTD | PMID:30816183 more ... | bisphenol A | decreases expression | ISO | RGD:736826 | 6480464 | bisphenol A results in decreased expression of RBBP9 mRNA | CTD | PMID:33221593 | Bisphenol B | increases expression | ISO | RGD:1349258 | 6480464 | bisphenol B results in increased expression of RBBP9 protein | CTD | PMID:34186270 | bisphenol F | increases expression | ISO | RGD:1349258 | 6480464 | bisphenol F results in increased expression of RBBP9 protein | CTD | PMID:34186270 | cadmium atom | multiple interactions | ISO | RGD:1349258 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RBBP9 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1349258 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RBBP9 mRNA | CTD | PMID:35301059 | cisplatin | multiple interactions | ISO | RGD:1349258 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of RBBP9 mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | RGD:1349258 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RBBP9 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1349258 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RBBP9 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | RGD:1349258 | 6480464 | Copper Sulfate results in decreased expression of RBBP9 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | RGD:1349258 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP9 mRNA | CTD | PMID:19167446 | coumestrol | increases expression | ISO | RGD:1349258 | 6480464 | Coumestrol results in increased expression of RBBP9 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | RGD:1349258 | 6480464 | Cyclosporine results in decreased expression of RBBP9 mRNA | CTD | PMID:25562108 | dioxygen | multiple interactions | ISO | RGD:736826 | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of RBBP9 mRNA | CTD | PMID:30529165 | disodium selenite | decreases expression | ISO | RGD:1349258 | 6480464 | Sodium Selenite results in decreased expression of RBBP9 mRNA | CTD | PMID:18175754 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of RBBP9 mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | ISO | RGD:1349258 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP9 mRNA | CTD | PMID:19167446 | epoxiconazole | decreases expression | ISO | RGD:736826 | 6480464 | epoxiconazole results in decreased expression of RBBP9 mRNA | CTD | PMID:35436446 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of RBBP9 mRNA | CTD | PMID:30307764 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of RBBP9 mRNA | CTD | PMID:24136188 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of RBBP9 mRNA | CTD | PMID:33387578 | ivermectin | decreases expression | ISO | RGD:1349258 | 6480464 | Ivermectin results in decreased expression of RBBP9 protein | CTD | PMID:32959892 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of RBBP9 mRNA | CTD | PMID:30467583 | methylparaben | decreases expression | ISO | RGD:1349258 | 6480464 | methylparaben results in decreased expression of RBBP9 mRNA | CTD | PMID:31745603 | N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of RBBP9 mRNA | CTD | PMID:20360939 | nickel sulfate | decreases expression | ISO | RGD:1349258 | 6480464 | nickel sulfate results in decreased expression of RBBP9 mRNA | CTD | PMID:22714537 | nicotine | increases expression | ISO | RGD:736826 | 6480464 | Nicotine results in increased expression of RBBP9 mRNA | CTD | PMID:17997037 | paclitaxel | decreases expression | ISO | RGD:1349258 | 6480464 | Paclitaxel results in decreased expression of RBBP9 mRNA | CTD | PMID:15000894 | paracetamol | decreases expression | ISO | RGD:1349258 | 6480464 | Acetaminophen results in decreased expression of RBBP9 mRNA | CTD | PMID:21420995, PMID:26690555 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RBBP9 mRNA | CTD | PMID:33387578 | phenobarbital | affects expression | ISO | RGD:736826 | 6480464 | Phenobarbital affects the expression of RBBP9 mRNA | CTD | PMID:23091169 | pirinixic acid | decreases expression | ISO | RGD:736826 | 6480464 | pirinixic acid results in decreased expression of RBBP9 mRNA | CTD | PMID:18445702 | pyrogallol | increases expression | ISO | RGD:736826 | 6480464 | Pyrogallol results in increased expression of RBBP9 mRNA | CTD | PMID:20362636 | rac-lactic acid | decreases expression | ISO | RGD:1349258 | 6480464 | Lactic Acid results in decreased expression of RBBP9 mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | ISO | RGD:1349258 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of RBBP9 mRNA | CTD | PMID:23557933 | sodium arsenite | decreases expression | ISO | RGD:1349258 | 6480464 | sodium arsenite results in decreased expression of RBBP9 mRNA | CTD | PMID:22714537 | sulforaphane | multiple interactions | ISO | RGD:736826 | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of RBBP9 mRNA | CTD | PMID:30529165 | sunitinib | decreases expression | ISO | RGD:1349258 | 6480464 | Sunitinib results in decreased expression of RBBP9 mRNA | CTD | PMID:31533062 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RBBP9 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | RGD:736826 | 6480464 | Carbon Tetrachloride results in decreased expression of RBBP9 mRNA | CTD | PMID:31919559 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of RBBP9 mRNA | CTD | PMID:30690589, PMID:31150632 | tetrachloromethane | increases methylation | EXP | | 6480464 | Carbon Tetrachloride results in increased methylation of RBBP9 promoter | CTD | PMID:30690589 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of RBBP9 mRNA | CTD | PMID:34492290 | torcetrapib | increases expression | ISO | RGD:1349258 | 6480464 | torcetrapib results in increased expression of RBBP9 mRNA | CTD | PMID:23228038 | trimellitic anhydride | decreases expression | ISO | RGD:736826 | 6480464 | trimellitic anhydride results in decreased expression of RBBP9 mRNA | CTD | PMID:19042947 | urethane | decreases expression | ISO | RGD:1349258 | 6480464 | Urethane results in decreased expression of RBBP9 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | RGD:736826 | 6480464 | Valproic Acid results in decreased expression of RBBP9 mRNA | CTD | PMID:21427059 | valproic acid | affects expression | ISO | RGD:1349258 | 6480464 | Valproic Acid affects the expression of RBBP9 mRNA | CTD | PMID:25979313 | zoledronic acid | increases expression | ISO | RGD:1349258 | 6480464 | zoledronic acid results in increased expression of RBBP9 mRNA | CTD | PMID:20977926 | |